Lilly To Pay Miss. $18.5M Over Zyprexa Marketing

Law360, New York (February 4, 2010, 5:26 PM EST) -- Eli Lilly and Co. Inc. has agreed to pay Mississippi $18.5 million to settle the state's allegations that the drugmaker marketed its antipsychotic Zyprexa for off-label uses and failed to reveal risks that the drug could cause diabetes.

Mississippi Attorney General Jim Hood on Thursday announced the settlement, which has been filed with the Circuit Court of Lafayette County. Under the agreement, the drugmaker has neither admitted nor denied wrongdoing, according to a consent judgment and assurance of voluntary compliance filed with the court.

In addition...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.